The White House withdrew Dr. Heidi Overton's nomination for FDA commissioner on Tuesday evening. The Senate health committee had planned to vote on her Wednesday morning, and Republicans were still counting votes when the news broke. Overton is a 37-year-old physician who works on the White House Domestic Policy Council, and President Trump picked her in August. Her bid stalled mainly over two things: how she answered questions about the abortion pill mifepristone, and her role in Trump's push to allow flavored vapes. The FDA hasn't had a Senate-confirmed leader since the White House forced out then-Commissioner Marty Makary in May. Acting Commissioner Kyle Diamantas runs it for now. Democrats take over the Senate in January, so Republicans have only a few weeks left to confirm anyone.
The White House Threw Away a Confirmable FDA Chief
This camp says Overton had the votes, and now temporary chiefs will run the FDA.
She had the votes. Senate health committee chair Bill Cassidy, a Louisiana Republican, said Tuesday night that "the White House abandoned a viable confirmation path for Dr. Overton." He said he'd been "having productive conversations with members" and believed "she would have had the votes to pass out of committee and pass the full Senate." Cassidy said his talks with her convinced him she "would follow the science." Two former FDA commissioners, Scott Gottlieb and Mark McClellan, backed her in September. They wrote that agency officials told them "she often backed them on difficult calls."
The White House wouldn't make abortion commitments. Cassidy said pro-life senators wanted "final assurances" from the administration on "life issues." He said the administration "withdrew Dr. Overton rather than make such commitments."
Acting chiefs would have less independence. On Sunday, before he'd decided how to vote, Cassidy asked whether the country wants "a series of short-term administrators who probably will have more influence from the secretary" instead of a permanent commissioner with "the ability to establish some independence." On Tuesday, he said that with so little time left, confirming a permanent FDA chief "will fall to Senate Democrats."
But She Stood in the Way of Kennedy's MAHA Agenda
This camp says Overton blocked the health agenda Trump's base voted for, and the FDA needs someone new.
The White House wants a different kind of FDA chief. A senior administration official told Axios that Overton "lacks the support on the Hill." The official added, "We need to go in a new direction at FDA, and everybody fully supports Secretary Kennedy's vision to Make America Healthy Again and get back to a more populist and common-sense approach to health in America."
She blocked MAHA policies from inside the White House. Calley Means, a former senior adviser to Health Secretary Robert F. Kennedy Jr., said on Face the Nation this month that "Heidi Overton was the biggest block to MAHA policies I encountered in the government." He said that after Makary left, "she drove the creation of the relaxed vaping strategy." Overton's spokesman answered that "two former FDA commissioners think otherwise." At her September hearing, Overton said career FDA scientists recommended the flavored-vape approvals because "so many adults are using flavors" to quit. MAHA activist Vani Hari, known as the Food Babe, cheered the withdrawal. She posted, "Another one bites the dust."
The tobacco industry pushed hard for flavored vapes. Makary, the former commissioner, said this month that "Big tobacco exploited their connections to administration and HHS officials" to pressure him "to approve fruit-flavored vapes that appeal to children—I wouldn't do it."
Pro-Life Groups Want the Next Pick to End Mail-Order Abortion Pills
This camp says no FDA nominee should move until the administration commits to stopping mifepristone by mail.
They still want mail-order abortion pills stopped before any vote. SBA Pro-Life America senior vice president Erik Baptist said after the withdrawal that "the administration must immediately end the Biden FDA's mail-order abortion-drug scheme." The group wants the next nominee to make that commitment before any vote. Last week, Baptist said senators must get the administration to "immediately restore the in-person dispensing requirement for mifepristone" before Overton moved forward.
She wouldn't say where she stood on the pill. In September, Overton told senators that mifepristone "was approved by the FDA as having met its safety and efficacy standard" and that the agency's safety study is "ongoing." Before the withdrawal on Tuesday, Missouri Republican Sen. Josh Hawley said she had promised to finish that study by March. An FDA court filing also puts the final report in March 2027.
And Abortion-Rights Groups Say She Threatened the Pill
This camp says Overton threatened abortion access, and the next Congress should pick the FDA chief.
She was a threat to the abortion pill. "Heidi Overton posed a serious threat to the future of medication abortion access," said Mini Timmaraju, president of Reproductive Freedom for All, after the withdrawal. Timmaraju said "our members kept the pressure on to tank her confirmation." Washington Democratic Sen. Patty Murray said earlier Tuesday that Overton "would not say what the science has said for years now: that the abortion pill is safe and effective."
The next Senate should choose. The Reproductive Freedom Alliance, a coalition of governors, said Tuesday that "the Senate should respect the election results and leave this nomination to the next Congress." Timmaraju warned that if Republicans "try to rush through another nominee," her group is "ready to keep fighting."
Where This Lands
Cassidy says Overton had the votes. He says the White House walked away rather than give pro-life senators the abortion commitments they wanted. The White House says she lacked support and that it wants an FDA chief who fits Kennedy's MAHA agenda. MAHA figures like Means had attacked Overton as a roadblock. Pro-life groups say the next nominee must commit to ending mail-order mifepristone before any vote. Abortion-rights groups say they helped sink her, and they want the Democratic Senate arriving in January to fill the job.
Sources
- CBS News: https://www.cbsnews.com/news/white-house-drops-heidi-overton-fda-commissioner/
- CBS News (confirmation struggle): https://www.cbsnews.com/news/trump-fda-nominee-heidi-overton-confirmation-struggle/
- NBC News: https://www.nbcnews.com/health/health-care/white-house-drops-dr-heidi-overton-fda-nomination-commissioner-rcna609883
- STAT: https://www.statnews.com/2026/11/17/heidi-overton-fda-commissioner-nomination-withdrawn/
- CNN: https://www.cnn.com/2026/11/17/politics/heidi-overton-white-house-drops-nomination-fda
- New York Post: https://nypost.com/2026/11/17/us-news/white-house-withdraws-heidi-overtons-fda-bid-after-nominee-received-bipartisan-pushback/
- STAT (Gottlieb and McClellan): https://www.statnews.com/2026/09/22/heidi-overton-fda-commissioner-confirmation-hearing/
- CBS News (Face the Nation transcript): https://www.cbsnews.com/news/calley-means-health-and-human-services-face-the-nation-transcript-11-08-2026/
- Fox News: https://www.foxnews.com/politics/white-house-pulls-trumps-fda-pick-heidi-overton-eve-senate-panel-vote
- SBA Pro-Life America: https://sbaprolife.org/newsroom/press-releases/sba-urges-senate-delay-overton-confirmation-until-trump-admin-commits-abortion-drug-reforms
- WORLD: https://wng.org/sift/sen-hawley-says-overton-promises-robust-mifepristone-review-1794960323
- The Guardian: https://www.theguardian.com/us-news/2026/nov/17/white-house-withdraws-heidi-overton-fda
- Sen. Patty Murray: https://www.murray.senate.gov/murray-says-anti-abortion-extremist-heidi-overtons-nomination-will-go-nowhere/
- Common Dreams: https://www.commondreams.org/news/dr-heidi-overton
- Government Executive: https://www.govexec.com/management/2026/09/fda-nominee-faces-bipartisan-scrutiny-over-vaccines-and-abortion-drug/416213/
- CNN (September hearing): https://www.cnn.com/2026/09/24/health/overton-senate-hearing-fda
- NBC News (Senate math): https://www.nbcnews.com/health/health-news/trump-fda-overton-confirmation-republican-doubts-rcna609067